Intelligence · Clinical Development
Pipeline search results
Programs matching “placebo” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 588 pipeline programs matching "placebo" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Rocatinlimab, Placebo for AMG 451
Amgen
Prurigo Nodularis
1 trial -
Sovateltide, Sovateltide matching placebo
Lacuna Pharma Pty Ltd
Acute cerebral ischemic stroke
1 trial -
Spesolimab, Placebo matching to Spesolimab
Boehringer Ingelheim
Hidradenitis Suppurativa (HS)
1 trial -
TOCILIZUMAB, Placebo of Tocilizumab
Pari Pharma GmbH
Giant cell arteritis with Cerebro-vascular involvement
1 trial -
Teplizumab, Matched placebo for test product
Sanofi-aventis Healthcare Pty Ltd
Nutritional and metabolic diseases
1 trial -
The placebo product consists of a soft capsul...
Fondazione Telethon ETS
Prevention of recurrence after a first episode of Venous Thromboembolism (VTE)
1 trial -
The placebo tablet composition is: Collodial...
The George Institute
Colon and rectal cancer tumor stage II-III, tumor with somatic alterationsin PIK3CA, PIK3R1 or PTEN
1 trial -
Tinlarebant 5 mg´s matching Placebo, LBS-008
ELITE PHARMACEUTICALS INC /NV/
Stargardt Disease
1 trial -
Tozorakimab, Tozorakimab-placebo
AstraZeneca AB
Severe viral lung infections
1 trial -
UI022 or UI023 and co-administration of matching placebo
United Therapeutics Europe Ltd
Peripheral Arterial Disease
1 trial -
Upadacitinib Placebo, Upadacitinib
AbbVie Deutschland GmbH & Co. KG
non-segmental vitiligo
1 trial -
Vedolizumab Placebo
Takeda
Hematopoietic Stem Cells
1 trial -
XPF-010, Placebo to match XPF-010
Xenon Pharmaceuticals
Major Depressive Disorder
1 trial -
a compound glutamine capsule/a compound glutamine capsule simulated placebo
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Mucositis
1 trial -
budesonide/formoterol 'as needed' + budesonide placebo bid
AstraZeneca
Asthma
1 trial -
elafibranor, Elafibranor Placebo
Ipsen
Primary Biliary Cholangitis (PBC)
1 trial -
elafibranor, Placebo
Ipsen
Primary Biliary Cholangitis
1 trial -
elafibranor, Placebo tablet
Ipsen
Primary Biliary Cholangitis
1 trial -
matched placebo for test product, Duvakitug
Sanofi-aventis Healthcare Pty Ltd
Immune system diseases
1 trial -
placebo
Boehringer Ingelheim
Pulmonary Fibrosis
1 trial -
placebo
Takeda
Osteoporosis
1 trial -
placebo
Jazz Pharmaceuticals Ireland Limited
Fibromyalgia
1 trial -
placebo
Takeda
Non-cancer Pain
1 trial -
placebo
Pfizer
Schizophrenia
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.